Search results
...Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory...
Morningstar· 5 days agoBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma 95.7% ...
Stacey Dash Slams Relapse Rumors, Says She’s Been “Clean” For Over 7 Years
VIBE via Yahoo News· 3 days agoStacey Dash found herself shutting down critics who speculated that she relapsed after admitting to...
All About Amy Winehouse's Parents, Mitch and Janis Winehouse
People via Yahoo News· 3 days agoIn 2016, the foundation opened Amy's Place, a recovery house that helps women working toward life...
$25 million plan takes shape for drug-recovery aid in Palm Beach County
Sun-Sentinel· 4 hours agoPalm Beach County wants to help curb the drug-related hardships faced by the community. During a workshop Tuesday, county commissioners will be presented with recommendations ...
Earnings call: Compugen outlines progress and plans in Q1 2024 earnings By Investing.com
Investing.com· 4 hours agoThe company highlighted its successful transition of AI-predicted drug targets to clinical trials...
Britney's Family Want to Put Her Back on Conservatorship, AllegeDrug Use Amid Paul Soliz Romance
AceShowbiz· 8 hours agoAccording to an exclusive from TMZ, Britney's family and inner circle are deeply troubled by her reported refusal to take mental health medication alongside persistent drinking and ...
Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
Zacks· 5 days agoFree Report) announced that the FDA has granted accelerated approval to the label expansion of chimeric antigen receptor (CAR) T cell therapy Breyanzi (lisocabtagene maraleucel; liso-cel). The ...
My doctor told me I had dandruff but the lumps were cancer
Yahoo Life UK· 5 days agoI can’t tell you how quickly the time has flown by but mentally, the illness has affected me badly....
FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe US Food and Drug Administration (FDA) has granted accelerated approval for Bristol Myers...
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 5 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...